CME Series | Long-Acting Anti-Infectives

This module focuses on the evolving landscape of long-acting anti-infective therapies, emphasizing recent advances in HIV prevention and treatment. Participants will explore current approved drugs and promising therapies in development, with a special focus on pediatric and adolescent populations. The module also addresses the challenges and opportunities for implementing long-acting antiretrovirals in resource-limited settings.

What Will Set You Apart?

By completing this module, you will:

• Understand current and emerging long-acting drugs and therapies for HIV prevention

• Evaluate the progress and challenges in developing long-acting anti-infective options for children and adolescents

• Discuss the implementation of long-acting antiretroviral therapies in resource-limited settings

Is This Program for You?

This module is designed for clinicians, researchers, program managers, and public health professionals involved in HIV prevention and treatment. It is particularly relevant for those focused on pediatric and adolescent care, as well as those working in resource-limited environments where innovative therapeutic options are critical.

What Will You Cover in This Module?

• Current and Future Perspectives in HIV Prevention

• The Long-Acting Anti-Infective Agents for Children and Adolescents

• Long-Acting Anti-Infectives in Resource-Limited Settings